FIGUR8
FIGUR8 is a Boston-based health technology company offering an FDA-registered wearable sensor platform that combines IMU and proprietary Surface Mechanomyography to deliver objective musculoskeletal assessments for physical therapy providers, payers, employers, and patients.
- Company typePrivate
- Founded2019
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What FIGUR8 does
FIGUR8 is a Boston-based health technology company that develops and commercializes the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor system combining inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to capture lab-grade biomechanics data during dynamic movement. Founded in 2019 as a spinout from MIT Media Lab, Massachusetts General Hospital Orthopaedics, and the Boston Red Sox, the company targets the musculoskeletal (MSK) care market by replacing subjective clinical assessments with objective biomarker data on joint motion and muscle function. Its platform captures over one million data points per assessment, against roughly six points in conventional tools, and feeds AI-driven features including the MovementMemo generative AI documentation tool and the Recovery Indicator recovery-intelligence module.
The company sells through a tiered channel-partner program organized into Local, Regional, and National tiers covering physical therapy clinic networks such as Physical Rehabilitation Network, CORA Physical Therapy, Team Rehab, and Upstream Rehabilitation, supplemented by direct enterprise sales to payers, self-insured employers, and workers' compensation organizations. Revenue derives from clinic subscriptions and per-assessment usage of the platform, hardware sales of the sensor device kits, and professional services including onboarding and training. The American Medical Association issued a technology-specific Category III CPT code for the IMU + sMMG sensor fusion system, establishing a reimbursement pathway and supporting ROI claims of a 4:1 clinic return and a 5:1 payer return alongside a reported 22% faster recovery rate for FIGUR8-enabled practices.
FIGUR8 raised approximately $44.5 million in venture funding across a 2019 seed, a 2021 Series A led by Taiwania Capital, and a 2023 Series A-1 led by First Spark Ventures. In 2025 the company launched MovementMemo and Recovery Indicator, expanded into employer and orthopedic telehealth channels through partnerships with Parker Hannifin and Best In Class MD, and appointed a new COO. In 2026 the company was acquired by Myant, integrating FIGUR8 into a larger connected-health platform.
FIGUR8 firmographics
Firmographics- Name
- FIGUR8
- Legal name
- FIGUR8 Inc
- Website
- https://figur8tech.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- FIGUR8 is a Boston-based health technology company offering an FDA-registered wearable sensor platform that combines IMU and proprietary Surface Mechanomyography to deliver objective musculoskeletal assessments for physical therapy providers, payers, employers, and patients.
- Ownership category
- akta.pro rank
FIGUR8 industry classification
Industry- Product category
- Musculoskeletal Health Assessment Technology
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
- akta.pro secondary industries
- Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
Keywords
Where FIGUR8 is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
FIGUR8 business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Revenue model
- Assessment Platform/Subscription: FIGUR8 enables clinics to use the bioMotion Assessment Platform for patient assessments. Revenue generated through clinic subscriptions and per-assessment usage. ROI calculator shows revenue opportunity per clinic based on payer mix.
- Wearable Hardware: Proprietary wearable sensor devices (device tray with sensors) used for assessments. Hardware components required for data collection during bioMotion assessments.
- Professional Services & Training: Training, onboarding, and support services for FIGUR8-enabled providers including video training resources, support materials, dedicated provider success manager, and live in-person onboarding for qualifying providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Annual | ROI Calculator shows potential revenue opportunity for clinics |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
FIGUR8 product offering
Product offeringCore offering
FIGUR8 develops and sells the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor-based system that combines inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to deliver objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. The platform includes AI-powered tools (MovementMemo, Recovery Indicator) and is offered to physical therapy providers, payers, and employers alongside proprietary wearable sensor hardware and training services.
Product overview
FIGUR8 is a health technology company offering the FDA-registered bioMotion Assessment Platform (bMAP) — a comprehensive wearable sensor and cloud analytics system for objective musculoskeletal (MSK) health assessment. The platform combines proprietary Surface Mechanomyography (sMMG) sensors with inertial measurement units (IMU) to capture lab-grade biomechanics data during movement assessments. The core offering is supplemented by MovementMemo (a generative AI tool for automated patient progress documentation), the Recovery Indicator (AI-driven recovery intelligence), and specialized solutions for healthcare providers, payers, and patients. The platform received a Category III CPT code from the American Medical Association, enabling reimbursement for the MSK assessment technology.
Differentiator
Problem solved
Functional benefit
Products and services
- bioMotion Assessment Platform (bMAP) FDA-registered wearable sensor platform combining IMU and Surface Mechanomyography (sMMG) sensors to provide objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. Used by physical therapy providers, payers, employers, and orthopedic specialists.
- Device Tray (Assessment Device Kit) Proprietary hardware kit containing all sensors and devices required to perform bioMotion assessments, used for storage and charging between sessions. Sold to provider and employer customers alongside the bMAP platform.
Quantifiable outcome
- 22% faster recovery rates for FIGUR8-enabled clinical practices
- +3 more outcomes
Companies that use FIGUR8
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
FIGUR8 technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
FIGUR8 partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered minor, major and core.
- ARPA-H Investor Catalyst HubminorFIGUR8 selected as spoke member of nationwide network working to accelerate transformative health solutions through collaboration with innovators.
- Best In Class MDmajorPartnership with leading orthopedic telehealth platform to combine precision MSK analytics with world-class orthopedic care. First offering combining MSK sensor technology with top orthopedic physician access.
- Parker Hannifin Quick Coupling DivisionmajorFortune 250 global leader in motion and control technologies partnered for deployment of FIGUR8's MSK health technology in select Parker manufacturing facilities. Focus on workplace MSK health and injury prevention.
- ToppanminorPilot test for online fitness instruction using musculoskeletal sensors, enabling personalized training for functional improvement based on objective quantitative data.
- Physical Rehabilitation Network (PRN)majorNational PT network partner surpassing 10,000 patient assessments using FIGUR8's bMAP. FIGUR8 provides training, onsite training, and continued support for PRN care providers.
- CORA Physical TherapymajorNational PT provider network using FIGUR8 technology for objective MSK assessments across their clinic network.
- Team RehabmajorPhysical therapy provider partner implementing FIGUR8 assessments for injured workers including work-related motor vehicle accidents.
- Upstream RehabilitationmajorLargest outpatient physical therapy provider partnering with FIGUR8 for technology evaluation and utilization in patient care.
- American Physical Therapy Association (APTA)coreFIGUR8 signed APTA Digital Transparency pledge. Active participation in APTA conferences and events. FIGUR8 contributes to MSK data standards discussions within PT profession.
- MIT (Massachusetts Institute of Technology)coreFIGUR8 originated as collaboration between MIT scientists, Massachusetts General Hospital Orthopaedics, and Boston Red Sox. MIT Media Lab spinout with founding technology from MIT research.
- Massachusetts General Hospital OrthopaedicscoreClinical collaboration partner in original founding of FIGUR8. Research collaboration for MSK diagnostic technology development.
- Boston Red SoxcoreOriginal founding collaboration for MSK health technology development. Boston Red Sox Sports Science Lab contributed to biomechanics research that led to FIGUR8 technology.
Scale indicators6 records
Recent moves8 records
Expansion highlights7 records
FIGUR8 competitors and assessment
Company assessmentDirect peers
- DARI Motion: Markerless, camera-based motion-capture system providing objective MSK and biomechanical assessment for physical therapy, sports performance, and occupational health — directly comparable to FIGUR8 in clinical use case and target buyer.
- Kinesis QT9: Provides quantitative functional capacity and movement assessment tools used by physical therapy providers, employers, and payers for MSK evaluation and return-to-work decisions.
- Physimax: AI-driven markerless motion analysis platform for MSK injury risk screening, rehabilitation tracking, and orthopedic assessment — overlaps with FIGUR8 on objective biomechanics and PT/sports medicine customers.
- Vald Health (ForceDecks / NordBord / HumanTrak): Offers force-plate and motion-capture systems widely used by physical therapists and sports organizations to quantify strength, balance, and movement — a comparable objective-assessment vendor to FIGUR8 in rehab and sports settings.
- Biodex Medical Systems: Manufactures clinical rehabilitation and MSK evaluation equipment used in physical therapy clinics and hospitals, addressing similar objective-assessment and rehabilitation use cases as FIGUR8.
- BTS Bioengineering: Provider of clinical-grade gait, motion-analysis, and surface EMG/EMG systems for rehabilitation and biomechanics research — a longstanding player in the same objective MSK and rehabilitation-assessment category as FIGUR8.
- Myomo: Medical device company combining wearable EMG-driven orthotics with software for MSK and neurological rehabilitation — overlaps with FIGUR8 on wearable MSK sensors and rehab-provider customers.
Broad incumbents
- Hinge Health: Large-scale digital MSK care platform combining wearable sensors, exercise therapy, and coaching for employers and payers. A broader incumbent that competes with FIGUR8 for payer and employer MSK budgets even though its care model differs.
- Kaia Health: Digital MSK and chronic pain platform used by employers and health plans, providing an adjacent solution in the value-based MSK care market where FIGUR8 sells to payers and employers.
- Sword Health: Virtual MSK care provider combining digital exercise therapy with human clinicians for employers and health plans — competes for the same payer and employer budgets and overlaps with FIGUR8's objective-assessment narrative.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FIGUR8 social profiles
Digital presenceFIGUR8 compliance and trust
Trust signalCompliance5 records
FIGUR8 financial estimates
Financial estimateRevenue estimate
Valuation estimate
FIGUR8 leadership team
Management profileNumber of profiles
Profiles11 records
FIGUR8 funding detail
Funding detailFunding overview
Funding rounds7 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FIGUR8 M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FIGUR8
What does FIGUR8 do?
FIGUR8 develops and sells the FDA-registered bioMotion Assessment Platform (bMAP), a wearable sensor-based system that combines inertial measurement units (IMU) with proprietary Surface Mechanomyography (sMMG) to deliver objective, lab-grade biomechanics data for musculoskeletal health assessment, injury recovery monitoring, and treatment planning. The platform includes AI-powered tools (MovementMemo, Recovery Indicator) and is offered to physical therapy providers, payers, and employers alongside proprietary wearable sensor hardware and training services.
Is FIGUR8 a public or private company?
FIGUR8 is a private company. It is classified as corporate owned and is currently acquired.
When was FIGUR8 founded?
FIGUR8 was founded in 2019. It employs 11 to 50 people.
Where is FIGUR8 based?
FIGUR8 is headquartered in Boston, United States, in the North America region.
How does FIGUR8 make money?
Three revenue lines are on record. Assessment Platform/Subscription is the primary driver. The others are wearable Hardware and professional Services & Training.
Who are FIGUR8's main competitors?
Direct peers on record are DARI Motion, Kinesis QT9, Physimax, Vald Health (ForceDecks / NordBord / HumanTrak), Biodex Medical Systems, BTS Bioengineering and Myomo. Broad incumbents are Hinge Health, Kaia Health and Sword Health.
Does FIGUR8 have an API?
No public API is recorded for FIGUR8.
What industry is FIGUR8 in?
FIGUR8's product category is Musculoskeletal Health Assessment Technology. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.